Abstract B134: The p38MAPK inhibitor LY2228820 dimesylate, in combination with cytotoxic agents, displays strong antitumor activity in human glioblastoma, multiple myeloma, and other mouse xenograft models.Susan E. Pratt, Louis F. Stancato, Robert M. Campbell et al.|Molecular Cancer Therapeutics|2011Cited by 0
Abstract 4594: LY4584180, a novel BCL6 molecular glue, demonstrates antitumor efficacy in preclinical models of B Cell NHLCandace Langan, Nathan A. Brooks, Bonita D. Jones et al.|Cancer Research|2026Cited by 0